ProQR Therapeutics PRQR
NASDAQ PRQR
$1.37 -0.01 (-0.72%)
At close: Oct 21, 2026 · 4:00 PM EDT

ProQR Therapeutics (PRQR) Receivables - Other (2013 - 2025)

Updated

ProQR Therapeutics' Receivables - Other came in at $1.72 million for the quarter ended Sep 30, 2025, up 102.8% from $845,629 a year earlier and up 13.0% from the prior quarter.

Analysis

ProQR Therapeutics (PRQR) Receivables - Other (2013 - 2025) Analysis & Trends

As of Dec 31, 2024, ProQR Therapeutics' Receivables - Other was $903,753, up 12.1% from the prior year.

  • Receivables - Other has increased in each of the last three years, with a five-year compound annual growth rate of 18.9% (years ended Dec 2019 to Dec 2024).
  • Going back by year, Receivables - Other was $805,880 in the year ended Dec 31, 2023 (+103.9%), $395,233 in the year ended Dec 31, 2022 (+24.6%), $317,150 in the year ended Dec 31, 2021 (-26.7%) and $432,732 in the year ended Dec 31, 2020 (+13.6%).
  • The five-year range for quarterly Receivables - Other is $306,584 (the quarter ended Dec 31, 2021) to $4.36 million (the quarter ended Jun 30, 2024).
  • Year-over-year, Receivables - Other increased in three of the last six quarters, with growth averaging 9.0%.
  • The fastest year-over-year change in Receivables - Other over five years came in the quarter ended Dec 31, 2023 (growth of 109.5%), and the weakest in the quarter ended Sep 30, 2024 (a decline of 70.5%).
  • Business Quant data shows PRQR's Receivables - Other at $1.52 million (quarter ended Jun 30, 2025), $1.81 million (quarter ended Mar 31, 2025) and $892,277 (quarter ended Dec 31, 2024) in the three quarters before the quarter ended Sep 30, 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 ProQR Therapeutics 145.89 Mn -314.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 1.72 Mn
Jun 30, 2025 1.57 Mn
Mar 31, 2025 1.87 Mn
Dec 31, 2024 868,913.69
Sep 30, 2024 860,075.76
Jun 30, 2024 4.34 Mn
Mar 31, 2024 2.73 Mn
Dec 31, 2023 824,580.27
Sep 30, 2023 2.78 Mn
Dec 31, 2022 399,778.25
Dec 31, 2021 303,510.75
Dec 31, 2020 466,166.08
Dec 31, 2019 380,878.11
Dec 31, 2018 1.03 Mn
Dec 31, 2017 87,174.58
Dec 31, 2016 1.24 Mn
Sep 30, 2014 243,664.10
Dec 31, 2013 81,479.33
API Access

ProQR Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=PRQR&period=max&api_key=YOUR_API_KEY